Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs
-
* Corresponding author: Hong Liu-Seifert liu-seifert_hong@lilly.com
BMC Medicine 2005, 3:21 doi:10.1186/1741-7015-3-21
Accesses
- Last 30 days: 75 accesses
- Last 365 days: 771 accesses
- All time: 11044 accesses